Correlation Engine 2.0
Clear Search sequence regions


  • adenocarcinoma (3)
  • CD10 (4)
  • diagnosis (1)
  • endometrioid carcinomas (9)
  • female (1)
  • GATA3 (5)
  • helps (1)
  • humans (1)
  • mesonephros (1)
  • thyroid (1)
  • TTF1 (4)
  • tumors focal (1)
  • uterus (1)
  • Sizes of these terms reflect their relevance to your search.

    Immunohistochemical markers shown to be useful in identifying/confirming mesonephric/mesonephric-like differentiation (MLD markers) include thyroid transcription factor (TTF1), GATA-binding protein 3 (GATA3), and cluster of differentiation 10 (CD10). Only a few studies have examined the expression levels of MLD markers in endometrial endometrioid carcinomas (EECs). This study aimed to analyze the frequency and pattern of MLD marker expression in low-grade EECs. We performed immunostaining for the detection of TTF1, GATA3, and CD10 expression in 50 low-grade EEC tissue samples and evaluated their staining proportion and intensity. Nine tumors (18.0%) expressed at least one MLD marker in varying proportions and intensities, and 2 of these tumors were positive for 2 MLD markers (TTF1/GATA3 and GATA3/CD10, respectively). Three (6.0%) tumors showed moderate-to-strong nuclear TTF1 immunoreactivity in ≤5% of the tumor cells. Five tumors (10.0%) had at least moderate nuclear GATA3 staining, and three of them displayed a staining proportion of ≥15%. Three tumors (6.0%) were focal (mean proportion, 15%) but strongly positive for CD10. Our findings indicate that a subset of EEC can express one or more MLD markers with varying staining proportions and intensities. Given that a diagnosis of uterine mesonephric-like adenocarcinoma should be established based on a combination of characteristic histologic features, unique immunophenotypes, and confirmed molecular findings, pathologists should not exclude EEC based only on the presence of focal immunoreactivity for MLD markers. Awareness of the atypical expression patterns of MLD markers in EEC helps pathologists avoid misdiagnosing EEC as a uterine mesonephric-like adenocarcinoma. Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

    Citation

    Yurimi Lee, Sangjoon Choi, Hyun-Soo Kim. Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in Low-grade Endometrial Endometrioid Carcinoma. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2024 May 01;43(3):221-232

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37566876

    View Full Text